JP2010505874A5 - - Google Patents

Info

Publication number

JP2010505874A5

JP2010505874A5 JP2009531593A JP2009531593A JP2010505874A5 JP 2010505874 A5 JP2010505874 A5 JP 2010505874A5 JP 2009531593 A JP2009531593 A JP 2009531593A JP 2009531593 A JP2009531593 A JP 2009531593A JP 2010505874 A5 JP2010505874 A5 JP 2010505874A5

Authority

JP

Japan

Prior art keywords

polypeptide

monoclonal antibody

epo

conjugate

antibody against

Prior art date

2007-10-03

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 229920001184 polypeptide Polymers 0.000 claims 82
• 102000004196 processed proteins & peptides Human genes 0.000 claims 82
• 108090000765 processed proteins & peptides Proteins 0.000 claims 82
• 238000000034 method Methods 0.000 claims 78
• 102000003951 Erythropoietin Human genes 0.000 claims 49
• 108090000394 Erythropoietin Proteins 0.000 claims 49
• 229940105423 erythropoietin Drugs 0.000 claims 49
• OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical group [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 claims 49
• 125000003147 glycosyl group Chemical group 0.000 claims 31
• 239000000203 mixture Substances 0.000 claims 29
• 229920000233 poly(alkylene oxides) Polymers 0.000 claims 24
• 239000008194 pharmaceutical composition Substances 0.000 claims 18
• 125000005647 linker group Chemical group 0.000 claims 17
• 229960000301 factor viii Drugs 0.000 claims 12
• 230000013595 glycosylation Effects 0.000 claims 12
• 238000006206 glycosylation reaction Methods 0.000 claims 12
• 102100034925 P-selectin glycoprotein ligand 1 Human genes 0.000 claims 11
• 108010054395 P-selectin ligand protein Proteins 0.000 claims 11
• 239000012616 hydrophobic interaction chromatography medium Substances 0.000 claims 10
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 9
• 102000051366 Glycosyltransferases Human genes 0.000 claims 9
• 108700023372 Glycosyltransferases Proteins 0.000 claims 9
• 230000006378 damage Effects 0.000 claims 9
• 208000014674 injury Diseases 0.000 claims 9
• 239000002609 medium Substances 0.000 claims 9
• 229920001223 polyethylene glycol Polymers 0.000 claims 9
• 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 claims 8
• 108010049870 Bone Morphogenetic Protein 7 Proteins 0.000 claims 8
• 102000003928 Bone morphogenetic protein 15 Human genes 0.000 claims 8
• 108090000349 Bone morphogenetic protein 15 Proteins 0.000 claims 8
• 102100024506 Bone morphogenetic protein 2 Human genes 0.000 claims 8
• 102100022544 Bone morphogenetic protein 7 Human genes 0.000 claims 8
• 108010022366 Carcinoembryonic Antigen Proteins 0.000 claims 8
• 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 claims 8
• 102000011022 Chorionic Gonadotropin Human genes 0.000 claims 8
• 108010062540 Chorionic Gonadotropin Proteins 0.000 claims 8
• 108010054218 Factor VIII Proteins 0.000 claims 8
• 102000001690 Factor VIII Human genes 0.000 claims 8
• 102000004042 Fibroblast Growth Factor-23 Human genes 0.000 claims 8
• 108090000569 Fibroblast Growth Factor-23 Proteins 0.000 claims 8
• 102000003972 Fibroblast growth factor 7 Human genes 0.000 claims 8
• 108090000385 Fibroblast growth factor 7 Proteins 0.000 claims 8
• 102000012673 Follicle Stimulating Hormone Human genes 0.000 claims 8
• 108010079345 Follicle Stimulating Hormone Proteins 0.000 claims 8
• 102400000326 Glucagon-like peptide 2 Human genes 0.000 claims 8
• 101800000221 Glucagon-like peptide 2 Proteins 0.000 claims 8
• 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims 8
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims 8
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims 8
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims 8
• 241000238631 Hexapoda Species 0.000 claims 8
• 102000002265 Human Growth Hormone Human genes 0.000 claims 8
• 108010000521 Human Growth Hormone Proteins 0.000 claims 8
• 239000000854 Human Growth Hormone Substances 0.000 claims 8
• 102100020873 Interleukin-2 Human genes 0.000 claims 8
• 108010002350 Interleukin-2 Proteins 0.000 claims 8
• 108010036012 Iodide peroxidase Proteins 0.000 claims 8
• 102100033448 Lysosomal alpha-glucosidase Human genes 0.000 claims 8
• 241000725643 Respiratory syncytial virus Species 0.000 claims 8
• 102000014267 Thyroid peroxidases Human genes 0.000 claims 8
• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 claims 8
• 102100040247 Tumor necrosis factor Human genes 0.000 claims 8
• 102000005840 alpha-Galactosidase Human genes 0.000 claims 8
• 108010030291 alpha-Galactosidase Proteins 0.000 claims 8
• 108010028144 alpha-Glucosidases Proteins 0.000 claims 8
• 229940098448 fibroblast growth factor 7 Drugs 0.000 claims 8
• 229940028334 follicle stimulating hormone Drugs 0.000 claims 8
• 108020001507 fusion proteins Proteins 0.000 claims 8
• 102000037865 fusion proteins Human genes 0.000 claims 8
• TWSALRJGPBVBQU-PKQQPRCHSA-N glucagon-like peptide 2 Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O)[C@@H](C)CC)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)CC)C1=CC=CC=C1 TWSALRJGPBVBQU-PKQQPRCHSA-N 0.000 claims 8
• 229940084986 human chorionic gonadotropin Drugs 0.000 claims 8
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 8
• 102000003298 tumor necrosis factor receptor Human genes 0.000 claims 8
• 102000004411 Antithrombin III Human genes 0.000 claims 7
• 108090000935 Antithrombin III Proteins 0.000 claims 7
• 108010069196 Neural Cell Adhesion Molecules Proteins 0.000 claims 7
• 102100023616 Neural cell adhesion molecule L1-like protein Human genes 0.000 claims 7
• 102000004230 Neurotrophin 3 Human genes 0.000 claims 7
• 108090000742 Neurotrophin 3 Proteins 0.000 claims 7
• 229960005348 antithrombin iii Drugs 0.000 claims 7
• 229940032018 neurotrophin 3 Drugs 0.000 claims 7
• 102000003973 Fibroblast growth factor 21 Human genes 0.000 claims 6
• 108090000376 Fibroblast growth factor 21 Proteins 0.000 claims 6
• 208000027418 Wounds and injury Diseases 0.000 claims 6
• 238000004519 manufacturing process Methods 0.000 claims 6
• 239000002773 nucleotide Substances 0.000 claims 6
• 125000003729 nucleotide group Chemical group 0.000 claims 6
• 239000011347 resin Substances 0.000 claims 6
• 229920005989 resin Polymers 0.000 claims 6
• 125000005629 sialic acid group Chemical group 0.000 claims 6
• 125000003275 alpha amino acid group Chemical group 0.000 claims 5
• 239000012501 chromatography medium Substances 0.000 claims 5
• 210000003743 erythrocyte Anatomy 0.000 claims 5
• 238000004191 hydrophobic interaction chromatography Methods 0.000 claims 5
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 claims 4
• 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims 4
• 102000016289 Cell Adhesion Molecules Human genes 0.000 claims 4
• 108010067225 Cell Adhesion Molecules Proteins 0.000 claims 4
• 102000016911 Deoxyribonucleases Human genes 0.000 claims 4
• 108010053770 Deoxyribonucleases Proteins 0.000 claims 4
• 108010014173 Factor X Proteins 0.000 claims 4
• 108010071289 Factor XIII Proteins 0.000 claims 4
• 101710160621 Fusion glycoprotein F0 Proteins 0.000 claims 4
• 102000004547 Glucosylceramidase Human genes 0.000 claims 4
• 108010017544 Glucosylceramidase Proteins 0.000 claims 4
• 102000003886 Glycoproteins Human genes 0.000 claims 4
• 108090000288 Glycoproteins Proteins 0.000 claims 4
• 102000007625 Hirudins Human genes 0.000 claims 4
• 108010007267 Hirudins Proteins 0.000 claims 4
• 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims 4
• 102000004627 Iduronidase Human genes 0.000 claims 4
• 108010003381 Iduronidase Proteins 0.000 claims 4
• 102000004877 Insulin Human genes 0.000 claims 4
• 108090001061 Insulin Proteins 0.000 claims 4
• 102000006992 Interferon-alpha Human genes 0.000 claims 4
• 108010047761 Interferon-alpha Proteins 0.000 claims 4
• 102000003996 Interferon-beta Human genes 0.000 claims 4
• 108090000467 Interferon-beta Proteins 0.000 claims 4
• 102000008070 Interferon-gamma Human genes 0.000 claims 4
• 108010074328 Interferon-gamma Proteins 0.000 claims 4
• 102000010789 Interleukin-2 Receptors Human genes 0.000 claims 4
• 108010038453 Interleukin-2 Receptors Proteins 0.000 claims 4
• 102000016267 Leptin Human genes 0.000 claims 4
• 108010092277 Leptin Proteins 0.000 claims 4
• 102000018697 Membrane Proteins Human genes 0.000 claims 4
• 108010052285 Membrane Proteins Proteins 0.000 claims 4
• OVRNDRQMDRJTHS-RTRLPJTCSA-N N-acetyl-D-glucosamine Chemical group CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-RTRLPJTCSA-N 0.000 claims 4
• 102000035195 Peptidases Human genes 0.000 claims 4
• 108091005804 Peptidases Proteins 0.000 claims 4
• 239000004365 Protease Substances 0.000 claims 4
• 102000003978 Tissue Plasminogen Activator Human genes 0.000 claims 4
• 108090000373 Tissue Plasminogen Activator Proteins 0.000 claims 4
• 102000004338 Transferrin Human genes 0.000 claims 4
• 108090000901 Transferrin Proteins 0.000 claims 4
• 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 4
• 102000003990 Urokinase-type plasminogen activator Human genes 0.000 claims 4
• 108090000435 Urokinase-type plasminogen activator Proteins 0.000 claims 4
• 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims 4
• 102100039037 Vascular endothelial growth factor A Human genes 0.000 claims 4
• 239000002253 acid Substances 0.000 claims 4
• 238000005349 anion exchange Methods 0.000 claims 4
• 102000006995 beta-Glucosidase Human genes 0.000 claims 4
• 108010047754 beta-Glucosidase Proteins 0.000 claims 4
• 230000000295 complement effect Effects 0.000 claims 4
• 230000037430 deletion Effects 0.000 claims 4
• 238000012217 deletion Methods 0.000 claims 4
• 230000001419 dependent effect Effects 0.000 claims 4
• 206010013023 diphtheria Diseases 0.000 claims 4
• 229940012444 factor xiii Drugs 0.000 claims 4
• 150000004676 glycans Chemical group 0.000 claims 4
• 208000002672 hepatitis B Diseases 0.000 claims 4
• 229940006607 hirudin Drugs 0.000 claims 4
• WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 claims 4
• 229940125396 insulin Drugs 0.000 claims 4
• 229960003130 interferon gamma Drugs 0.000 claims 4
• 229960001388 interferon-beta Drugs 0.000 claims 4
• 229940039781 leptin Drugs 0.000 claims 4
• NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 claims 4
• GCYXWQUSHADNBF-AAEALURTSA-N preproglucagon 78-108 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 GCYXWQUSHADNBF-AAEALURTSA-N 0.000 claims 4
• 239000012581 transferrin Substances 0.000 claims 4
• 239000002753 trypsin inhibitor Substances 0.000 claims 4
• 229960005356 urokinase Drugs 0.000 claims 4
• 241000124008 Mammalia Species 0.000 claims 3
• OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 claims 3
• MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 claims 3
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical group CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 3
• 102000003838 Sialyltransferases Human genes 0.000 claims 3
• 108090000141 Sialyltransferases Proteins 0.000 claims 3
• 125000000539 amino acid group Chemical group 0.000 claims 3
• MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims 3
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 3
• 238000005277 cation exchange chromatography Methods 0.000 claims 3
• 210000004027 cell Anatomy 0.000 claims 3
• 239000003937 drug carrier Substances 0.000 claims 3
• 230000004064 dysfunction Effects 0.000 claims 3
• 230000002708 enhancing effect Effects 0.000 claims 3
• 230000002757 inflammatory effect Effects 0.000 claims 3
• 208000028867 ischemia Diseases 0.000 claims 3
• 230000035772 mutation Effects 0.000 claims 3
• 229950006780 n-acetylglucosamine Drugs 0.000 claims 3
• 230000008520 organization Effects 0.000 claims 3
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
• 231100000614 poison Toxicity 0.000 claims 3
• 229920001451 polypropylene glycol Polymers 0.000 claims 3
• 230000000451 tissue damage Effects 0.000 claims 3
• 231100000827 tissue damage Toxicity 0.000 claims 3
• 239000003440 toxic substance Substances 0.000 claims 3
• 230000008733 trauma Effects 0.000 claims 3
• 102100022641 Coagulation factor IX Human genes 0.000 claims 2
• 102100023804 Coagulation factor VII Human genes 0.000 claims 2
• 102000004190 Enzymes Human genes 0.000 claims 2
• 108090000790 Enzymes Proteins 0.000 claims 2
• 108010076282 Factor IX Proteins 0.000 claims 2
• 108010023321 Factor VII Proteins 0.000 claims 2
• 102000030902 Galactosyltransferase Human genes 0.000 claims 2
• 108060003306 Galactosyltransferase Proteins 0.000 claims 2
• 229940124158 Protease/peptidase inhibitor Drugs 0.000 claims 2
• 102000004357 Transferases Human genes 0.000 claims 2
• 108090000992 Transferases Proteins 0.000 claims 2
• 102000015395 alpha 1-Antitrypsin Human genes 0.000 claims 2
• 108010050122 alpha 1-Antitrypsin Proteins 0.000 claims 2
• 238000005571 anion exchange chromatography Methods 0.000 claims 2
• 238000004113 cell culture Methods 0.000 claims 2
• 229940088598 enzyme Drugs 0.000 claims 2
• 229960004222 factor ix Drugs 0.000 claims 2
• 229940012413 factor vii Drugs 0.000 claims 2
• 229940012426 factor x Drugs 0.000 claims 2
• 239000000835 fiber Substances 0.000 claims 2
• 239000003102 growth factor Substances 0.000 claims 2
• 239000000137 peptide hydrolase inhibitor Substances 0.000 claims 2
• 230000001225 therapeutic effect Effects 0.000 claims 2
• 108010047303 von Willebrand Factor Proteins 0.000 claims 2
• 102100036537 von Willebrand factor Human genes 0.000 claims 2
• 229960001134 von willebrand factor Drugs 0.000 claims 2
• 101710081722 Antitrypsin Proteins 0.000 claims 1
• 102100021852 Neuronal cell adhesion molecule Human genes 0.000 claims 1
• 101710130688 Neuronal cell adhesion molecule Proteins 0.000 claims 1
• 108010035766 P-Selectin Proteins 0.000 claims 1
• 102100023472 P-selectin Human genes 0.000 claims 1
• 125000002947 alkylene group Chemical group 0.000 claims 1
• 230000001475 anti-trypsic effect Effects 0.000 claims 1
• 238000006243 chemical reaction Methods 0.000 claims 1
• 230000010437 erythropoiesis Effects 0.000 claims 1
• 229930182830 galactose Natural products 0.000 claims 1
• 238000002955 isolation Methods 0.000 claims 1
• 239000000758 substrate Substances 0.000 claims 1
• 229960000187 tissue plasminogen activator Drugs 0.000 claims 1